Acorda Therapeutics (ACOR): Q4 EPS of $0.40 may not be comparable to consensus of $0.24. Revenue...

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor
Acorda Therapeutics (ACOR): Q4 EPS of $0.40 may not be comparable to consensus of $0.24. Revenue of $72.6M (+7.2% Y/Y) beats by $3.5M. (PR)